Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma
1996

Using Immunoscintigraphy to Diagnose Medullary Thyroid Carcinoma

Sample size: 25 publication Evidence: moderate

Author Information

Author(s): P Magnani, G Paganelli, C Songini, A Samuel, F Sudati, AG Siccardi, F Fazio

Primary Institution: INB-CNR, Institute H San Raffaele, University of Milan, Milan, Italy

Hypothesis

Can pretargeted immunoscintigraphy improve the diagnosis and follow-up of patients with medullary thyroid carcinoma?

Conclusion

Pretargeted immunoscintigraphy effectively localizes primary tumors and recurrences in patients with medullary thyroid carcinoma.

Supporting Evidence

  • Fifty-two lesions were visualized, with all primary tumors correctly diagnosed.
  • ISG detected 47 recurrences confirmed by cytology or histology.
  • The smallest lesion detected was a lymph node of 4 mm in diameter.

Takeaway

Doctors used a special imaging technique to find cancer in patients' necks, and it worked really well to spot tumors that other tests missed.

Methodology

The study involved 25 patients with medullary thyroid carcinoma who underwent a three-step immunoscintigraphy procedure using biotinylated monoclonal antibodies.

Limitations

The study had a small sample size and only tested immunogenicity in 11 patients.

Participant Demographics

The participants included 10 females and 15 males, aged 18 to 68 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication